Phase 2 Study of ABT ‐122, a TNF‐ and IL‐17A–Targeted Dual Variable Domain Immunoglobulin, in Psoriatic Arthritis With Inadequate Methotrexate Response

Arthritis&Rheumatology,Volume 0, Issue ja, -Not available-.

Source: Arthritis and Rheumatology - June 1, 2018 Category: Rheumatology Authors: Philip J. Mease , Mark C. Genovese , Michael E. Weinblatt , Paul M. Peloso , Kun Chen , Ahmed A. Othman , Yihan Li , Heikki T. Mansikka , Amit Khatri , Neil Wishart , John Liu Source Type: research